Skip to content

Med-stat.info

The latest health news

  • Coronavirus
  • Biotech
  • Health Tech
  • First Opinion
  • In the Lab
  • Pharma
Main Menu

Tag: Alzheimer’s

Biotech / Health / Pharma

FDA approves Alzheimer’s drug shown to moderately slow cognitive decline in early stages of the disease

06.01.2023

The Food and Drug Administration on Friday approved a new Alzheimer’s disease treatment that moderately slows cognitive decline in people with early-stage disease. The drug, called Leqembi, was developed by …

Read More
Biotech / Pharma

FDA, Biogen, and an Alzheimer’s drug approval: 8 key takeaways from congressional investigation

29.12.2022

Congressional investigators sorted through more than 500,000 pages of documents from the Food and Drug Administration and Biogen to chronicle how a controversial Alzheimer’s disease drug was approved, and how …

Read More
In the Lab

Mouse experiments with a decades-old drug suggest a new approach to Alzheimer’s treatment

11.10.2021

A generic drug used widely to treat swelling associated with hypertension and heart failure showed hints in early research that it may also prevent the devastating brain damage of Alzheimer’s …

Read More
Biotech

Newly disclosed FDA documents reveal agency’s unprecedented path to approving Aduhelm

22.06.2021

Chastened after a decisively negative review from outside advisers, the Food and Drug Administration convened a series of internal meetings in March and April where top officials hammered out a …

Read More
Health

Q&A: The CEO of the Alzheimer’s Association on the approval of Aduhelm — and why critics should stop dwelling on the decision

16.06.2021

Harry Johns is ready to stop talking about whether or not the Food and Drug Administration should have approved Aduhelm, the divisive new Alzheimer’s treatment that got the green light …

Read More
First Opinion

Opinion: If the FDA approves Biogen’s Alzheimer’s treatment, I won’t prescribe it

30.05.2021

Most visits to the memory center where I care for individuals living with Alzheimer’s disease end in disappointment. “Are there any new treatments, Dr. Karlawish?” patients or family members hopefully …

Read More
First Opinion

Opinion: Medicare: Cover amyloid PET scans and stop keeping people with dementia in the dark

25.05.2021

One morning in 2012, my wife Geri looked in the mirror and failed to recognize her own face. Our neurologist diagnosed Geri, a former health care executive and nurse, with …

Read More
Biotech

FDA scientists appear to offer major endorsement of Biogen’s controversial Alzheimer’s treatment

04.11.2020

STAT+ subscribers will have access to all-day coverage of the Friday advisory committee meeting to discuss Biogen’s Alzheimer’s drug, with regular updates on key presentations, interesting arguments, and eventually the …

Read More
Copyright © Med-stat.info
  • Terms of Service
  • Privacy Policy